US to partner with 50 countries to prevent future pandemics
Apr 16, 2024
The Biden Administration announced Tuesday that it will work with 50 nations worldwide to try to prevent global pandemics such as COVID-19, which brought the world to a standstill four years ago.
‘Misallocation’ of COVID-19 vaccines led to preventable deaths of older adults: study
By
Kimberly Bonvissuto
Apr 16, 2024
Older adults in New York City may have missed out on timely COVID-19 vaccinations — and possibly died — due to a misallocation of resources that allowed younger adults in wealthy neighborhoods to jump...
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Disease severity similar for RSV as unvaccinated COVID-19, influenza
Apr 05, 2024
The odds of invasive mechanical ventilation and death significantly increased for those with RSV versus vaccinated COVID and flu.
Nonhospitalized patients with post-COVID condition tolerate exercise
Apr 05, 2024
Patients with post-COVID condition show preserved lung and heart function at baseline and have lower peak volume of oxygen consumption.
Global adult mortality rates increased during COVID-19
Mar 26, 2024
An increase was seen during the pandemic period, following a decrease between 1950 and 2019; child mortality continued to drop during the pandemic.
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
Generalized joint hypermobility may increase risk for long COVID
Mar 26, 2024
Hypermobility also predicts greater fatigue levels.
No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.